Scarica l'app Stockscreener
22.05
3.86%
0.82
Precedente Chiudi:
$21.23
Aprire:
$21.19
Volume 24 ore:
2.03M
Relative Volume:
1.57
Capitalizzazione di mercato:
$2.38B
Reddito:
$247.00M
Utile/perdita netta:
$-249.00M
Rapporto P/E:
-7.1359
EPS:
-3.09
Flusso di cassa netto:
$-267.00M
1 W Prestazione:
+9.87%
1M Prestazione:
+22.16%
6M Prestazione:
+156.10%
1 anno Prestazione:
+54.41%
Intervallo 1D:
$20.82
$22.49
Intervallo di 1 settimana:
$19.44
$22.49
Portata 52W:
$6.50
$22.49
Arcus Biosciences Inc Stock (RCUS) Company Profile
Nome
Arcus Biosciences Inc
Settore
Industria
Telefono
(510) 694-6200
Indirizzo
3928 POINT EDEN WAY, HAYWARD, CA
Confronta RCUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
22.05 | 2.63B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | Iniziato | H.C. Wainwright | Neutral |
| 2024-10-08 | Iniziato | Wells Fargo | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Neutral |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-11-23 | Iniziato | Evercore ISI | Outperform |
| 2020-04-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-03-04 | Iniziato | Barclays | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-09-27 | Iniziato | Mizuho | Buy |
| 2019-05-24 | Ripresa | Citigroup | Buy |
| 2018-10-09 | Iniziato | Wedbush | Outperform |
| 2018-04-09 | Iniziato | Citigroup | Buy |
| 2018-04-09 | Iniziato | Goldman | Neutral |
| 2018-04-09 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Arcus Biosciences Inc Borsa (RCUS) Ultime notizie
Arcus Biosciences stock hits 52-week high at 22.13 USD By Investing.com - Investing.com Nigeria
What is the fair value estimate for Arcus Biosciences Inc. stock in 2025Portfolio Update Report & Stepwise Entry/Exit Trade Alerts - newser.com
How Arcus Biosciences Inc. stock benefits from digital adoptionRisk Management & Free Technical Confirmation Trade Alerts - newser.com
Is Arcus Biosciences Inc. stock vulnerable to rate hikesWeekly Stock Report & Technical Analysis for Trade Confirmation - newser.com
Is Arcus Biosciences Inc. stock positioned for digital transformationJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Arcus Biosciences (NYSE:RCUS) NYSE Composite Shows Biotech Energy - Kalkine Media
Will Arcus Biosciences Inc. stock benefit from automation2025 Momentum Check & Smart Money Movement Tracker - newser.com
How strong dollar benefits Arcus Biosciences Inc. stockQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
How dovish Fed policy supports Arcus Biosciences Inc. stock2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Is Arcus Biosciences Inc. stock cheap by valuation metrics2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Will Arcus Biosciences Inc. stock recover faster than industryWeekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com
Can Arcus Biosciences Inc. stock deliver strong Q4 earningsOptions Play & High Accuracy Trade Signal Alerts - newser.com
Is Arcus Biosciences Inc. stock a buy on dips2025 Big Picture & Safe Entry Zone Identification - newser.com
Does Arcus Biosciences Inc. show high probability of rebound2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What downside risks could hit Arcus Biosciences Inc. stockTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com
Arcus Biosciences Opens with 8.22% Gain, Contrasting S&P 500's Decline - Markets Mojo
Arcus Biosciences (NYSE: RCUS) to Present at Evercore and Citi Healthcare Conferences - Stock Titan
Madison Square Garden Sports Corp MS8 Stock Analysis and ForecastStock Watchlist Updates & Minimal Capital Growth Ideas - earlytimes.in
Shareholder Jaen Juan Carlos & Anita Galeana 2000 Trust Files To Sell 50,000 Of Arcus Biosciences Inc [RCUS] - TradingView
[144] Arcus Biosciences, Inc. SEC Filing - Stock Titan
Can Arcus Biosciences Inc. stock ride next bull market cycle - newser.com
How Arcus Biosciences Inc. stock reacts to job market dataWall Street Watch & Community Verified Swing Trade Signals - newser.com
Arcus Biosciences Inc Azioni (RCUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):